US 11505600
Methods of treating skin cancer by administering a PD-1 inhibitor
granted A61KA61K2039/505A61K2039/507
Quick answer
US patent 11505600 (Methods of treating skin cancer by administering a PD-1 inhibitor) held by REGENERON PHARMACEUTICALS, INC. expires Mon Nov 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Nov 22 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K2039/505, A61K2039/507, A61K2039/545, A61K2300/00